KeriCure Medical Achieves Milestone FDA Clearance for Revolutionary Field Shield Wound Dressing

Press Release

FOR IMMEDIATE RELEASE

KeriCure Medical Achieves Milestone FDA Clearance for Revolutionary Field Shield Wound Dressing

Tampa, FL – KeriCure Medical, a leader in advanced biotechnology solutions, proudly announces the FDA 510(k) clearance of its innovative Field Shield Wound Dressing, a first-of-its-kind multi-use spray on wound dressing designed for advanced wound management for both civilian applications and military requirements for prolonged field care and Tactical Combat Casualty Care (TCCC). This groundbreaking product is set to transform military medical protocols by offering a versatile, effective solution for managing a wide range of traumatic dermal injuries throughout the wound healing process.

Innovative Features Propel Field Care Forward

Field Shield Wound Dressing brings exceptional innovation to the forefront of military medicine with its unique combination of silver hydrosol antimicrobial and lidocaine for pain relief, integrated into KeriCure’s patented polymer barrier technology. This synergy creates an optimal healing environment, effectively addressing bacteria and fungi while addressing the urgent needs of wound care in challenging field conditions.

First of Its Kind

The journey to FDA clearance was a testament to the dressing's novel approach, taking three years to navigate the FDA’s rigorous evaluation process due to its unique characteristics. “Field Shield is the first multi-use spray on wound dressing of its kind, combining both pain management and antimicrobial effectiveness, which significantly contributed to the extended review period," explained Dr. Kerriann Greenhalgh, Founder, CEO, and CSO of KeriCure Medical. "Our team is thrilled that our perseverance has paid off and we can now offer this revolutionary product to enhance the effectiveness of military and emergency medical care for better healing with fewer complications."

Looking Ahead: Expanding Impact and Reach

As KeriCure Medical celebrates this significant achievement, the company is also focused on the next steps. Efforts to secure a National Stock Number (NSN) for Field Shield Wound Dressing are underway, ensuring that this essential tool reaches the hands of those who need it most, from military personnel to first responders to hospitals and wound clinics.

Join Us at NGAUS 2024

The KeriCure team is excited to showcase the Field Shield Wound Dressing at the upcoming NGAUS 146th General Conference & Exhibition in Detroit from August 23-26, 2024. Attendees are invited to visit the KeriCure booth to see firsthand how Field Shield is setting new standards in wound care.

For further information, please visit KeriCure Medical on PM13 Defense Solutions.

About KeriCure Medical

KeriCure Medical is a Tampa-based, SBA certified woman-owned small biotechnology firm specializing in the development of innovative and effective wound care solutions. Committed to pioneering advancements that meet the demands of modern medicine and military needs, KeriCure aims to provide products that promote natural, safe, and rapid recovery for all wounds, big and small.

Contact: Dr. Kerriann Greenhalgh, PhD CEO & CSO, KeriCure Medical Phone: 855-888-5374 Email: info@kericure.com

Pam Sovine